Target intelligence / Profile preview

Coiled-coil domain-containing 183 antisense RNA 1 (CCDC183-AS1)

Target
CCDC183-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Competing endogenous RNA (ceRNA)
01

Overview

Coiled-coil domain-containing 183 antisense RNA 1 (CCDC183-AS1) is a long noncoding RNA (lncRNA) located primarily in the cytoplasm, identified as playing an oncogenic role in cancers such as breast and bladder cancer[1][2][3][5]. CCDC183-AS1 functions as a competing endogenous RNA (ceRNA), sponging specific microRNAs (notably miR-3918 and miR-4731-5p), resulting in upregulation of oncogenes including fibroblast growth factor receptor 1 (FGFR1) and transcription factor 7 like 2 (TCF7L2)[1][2][3]. Its expression is transcriptionally regulated by the transcription factor MITF[2]. Elevated CCDC183-AS1 is associated with enhanced proliferation, migration, and invasion of cancer cells and correlates with poor clinical outcomes, suggesting a potential utility as a biomarker in cancer but no evidence supports its direct use as a drug target or receptor at present[1][2][3][5].

Other names
KIAA1984-AS1CCDC183-AS1
02

Mechanism of action

Acts as a ceRNA to sequester microRNAs (e.g., miR-3918, miR-4731-5p); Upregulates oncogenes (e.g., FGFR1, TCF7L2) through derepression by miRNA sponge activity

03

Biological functions

Regulation of gene expression (via miRNA sponging)Cell proliferationCell migrationCell invasionModulation of aerobic glycolysis
04

Disease associations

Breast cancer (BC)Bladder cancer (BCa)
05

Biomarkers

Elevated CCDC183-AS1 expression as a biomarker for poor prognosis in breast cancer[1][5]

Beyond the preview

Go deeper on Coiled-coil domain-containing 183 antisense RNA 1 (CCDC183-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil domain-containing 183 antisense RNA 1 (CCDC183-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call